|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2003-3-21
|
|
pubmed:abstractText |
The purpose of this study was to evaluate the efficacy and toxicity of oxaliplatin plus 5-fluorouracil (5-FU) and leucovorin (LV) in patients with metastatic breast cancer (MBC) previously treated with anthracyclines and taxanes.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0923-7534
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
14
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
537-42
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:12649097-Adult,
pubmed-meshheading:12649097-Aged,
pubmed-meshheading:12649097-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:12649097-Breast Neoplasms,
pubmed-meshheading:12649097-Disease Progression,
pubmed-meshheading:12649097-Female,
pubmed-meshheading:12649097-Fluorouracil,
pubmed-meshheading:12649097-Humans,
pubmed-meshheading:12649097-Infusions, Intravenous,
pubmed-meshheading:12649097-Injections, Intravenous,
pubmed-meshheading:12649097-Leucovorin,
pubmed-meshheading:12649097-Middle Aged,
pubmed-meshheading:12649097-Nervous System,
pubmed-meshheading:12649097-Neutropenia,
pubmed-meshheading:12649097-Organoplatinum Compounds,
pubmed-meshheading:12649097-Patient Compliance,
pubmed-meshheading:12649097-Thrombocytopenia,
pubmed-meshheading:12649097-Treatment Outcome
|
|
pubmed:year |
2003
|
|
pubmed:articleTitle |
Oxaliplatin plus high-dose leucovorin and 5-fluorouracil in pretreated advanced breast cancer: a phase II study.
|
|
pubmed:affiliation |
Second Department of Medical Oncology, Metaxas Memorial Cancer Hospital, Piraeus, Greece. pectasid@otenet.gr
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Clinical Trial, Phase II
|
